Given that synaptic loss is a critical hallmark of Alzheimer’s disease (AD), elucidating the mechanisms involving FAM19A5 could provide valuable insights into reversing synaptic loss in AD. This evidence concerns the gene TAFA5 and Alzheimer disease.